Myeloma Patients Europe (MPE) is running a survey for European myeloma patients to understand their quality of life and how this is impacted by treatment side-effects.
To gain knowledge about the current Multiple Myeloma (MM) disease situation in Europe, we ask MM patients to fill out a survey to assess their quality of life. If you are a myeloma patient, we would be grateful if you would take the time to complete the survey through the link on the MPE website: http://www.mpeurope.org/horizon-2020-patient-questionnaire/
We welcome responses from myeloma patients from any European country. The survey will take an estimated 20 minutes to complete.
How will the results be used?
The results of the survey will be used to develop the outcomes of MMPredict. By combining the responses of all participating patients, the aim is to have a better understanding of the most relevant quality of life issues for patients and relate these to specific treatments or disease characteristics. This will provide valuable insights to help the project consortium understand the kind of personalised medicine tool that could be valuable for patients and their doctors when choosing treatments.
Responses to the survey will remain confidential and will only be used within the context of the research.
Where can I find more information?
If you have any questions about the survey, please email firstname.lastname@example.org
On behalf of the project consortium, many thanks for your help.